concept

AGE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AGE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

43Connections
30Hypotheses
1Analyses
24Outgoing
19Incoming
2Experiments
1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameAGE
Key Genes/ProteinsAGER
Related DiseasesAD, ALS, neurodegenerative diseases, PD
Linked Hypotheses3 hypotheses

Wiki Pages (9)

Knowledge base pages for this entity

Canonical Page

hyp_367280

general · 3478 words

AGER/RAGE Protein

protein · 2601 words

RAGE Gene

gene · 1742 words

RAGE (Receptor for Advanced Glycation End Products) Modulator Therapy

therapeutic · 1417 words

Section 227: Advanced Glycation End Products and RAGE Therapy in CBS/PSP

therapeutic · 1410 words

Section 227: Advanced Glycation End Products and RAGE Therapy in CBS/PSP

therapeutic · 1246 words

Pathway Diagram

graph TD
    AGE["AGE"]
    AGE -->|"risk_factor_for"| Alzheimer_s_Disease["Alzheimer's Disease"]
    AGE -->|"risk_factor_for"| Parkinson_s_Disease["Parkinson's Disease"]
    AGE -->|"risk_factor_for"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
    AGE -->|"downregulates"| Microglial_Phagocytosis_of_Amy["Microglial Phagocytosis of Amyloid-beta"]
    AGE -->|"upregulates"| Microglial_Phagocytosis_of_Syn["Microglial Phagocytosis of Synapses"]
    AGE -->|"risk_factor_for"| Glaucoma["Glaucoma"]
    AGE -->|"modulates"| Mature_Neuronal_Fate["Mature Neuronal Fate"]
    AGE -->|"risk_factor_for"| Dementia["Dementia"]
    PARKINSON["PARKINSON"] -->|"increases_risk"| AGE
    autophagy["autophagy"] -->|"regulates"| AGE

Outgoing (24)

TargetRelationTypeStr
Alzheimer's Diseaserisk_factor_fordisease0.95
Dopaminergic Neurodegenerationassociated_withprocess0.95
Neuronal Fate Instabilityassociated_withphenotype0.95
Parkinson's Diseaserisk_factor_fordisease0.90
Amyotrophic Lateral Sclerosisrisk_factor_fordisease0.90

Incoming (19)

SourceRelationTypeStr
35361905breaks down withpaper0.90
25611508correlates withpaper0.90
26175670declined withpaper0.90
33132847increasespaper0.90
41224757is associated with delay inpaper0.90

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli 0.921 neurodegeneration TREM2 in Alzheimer's Disease: Mechanisms
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa 0.887 - Do β-amyloid plaques and neurofibrillary
Focused Ultrasound with Microbubble Contrast Agents for Anti 0.886 neurodegeneration Blood-brain barrier antibody transport m
TYROBP (DAP12) Conditional Antagonism for Early-Stage Neurop 0.844 neurodegeneration TREM2 agonism vs antagonism in DAM micro
Elevated CSF/Serum Albumin Quotient Predicts Neurodegenerati 0.825 - What blood-brain barrier permeability ch
TBK1 Loss Locks Microglia in an Aged/Senescent Transcription 0.776 ALS What are the mechanisms by which microgl
age-linked CpG drift is the actionable driver in: Are DNA me 0.750 neurodegeneration Are DNA methylation changes in neurodege
age-linked CpG drift is the actionable driver in: Are age-re 0.750 neurodegeneration Are age-related DNA methylation changes
Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Ove 0.745 neurodegeneration Epigenetic reprogramming in aging neuron
VPS35 retromer activation prevents endosomal tau templating 0.740 neurodegeneration Which tau propagation mechanism predomin
Mutant-dependent amplification is context-dependent and stro 0.740 neurodegeneration Do pathogenic LRRK2 mutations amplify vo
ATAC-seq accessibility separates causal from compensatory st 0.738 neurodegeneration Are age-related DNA methylation changes
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.735 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Context-Dependent Cx43 Modulation Based on Disease Stage 0.724 cell biology What is the relative contribution of con
protective chromatin remodeling defines the therapeutic wind 0.723 neurodegeneration Are age-related DNA methylation changes
Peripheral Monocyte/Macrophage Infiltration Mimicking Microg 0.693 neuroinflammation What causes IBA1 low/negative microglia
PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Su 0.661 neurodegeneration What upstream mechanisms trigger p53 act
Focused Ultrasound with Microbubble Contrast Agents 0.660 drug delivery Can IGFBPL1 therapeutics effectively cro
Plasma D-Dimer Elevation Reflects Fibrinogen Leakage and Sec 0.660 - What blood-brain barrier permeability ch
Radiation drives pericyte senescence through lysosome acidif 0.652 neurodegeneration What specific autophagy pathways are def
Age-Dependent TREM2 Signaling Disrupts Astrocyte-Microglia C 0.649 neurodegeneration Gene expression changes in aging mouse b
IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral 0.648 neuroinflammation How do B cells mechanistically orchestra
S100B as Active Pathogenic BBB-Disrupting Signal via RAGE/NF 0.647 - Blood-brain barrier permeability changes
C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macropha 0.640 neuroinflammation What are the specific molecular mechanis
Mitochondrial ROS from complex I and cardiolipin instability 0.640 neurodegeneration What mechanisms drive the self-amplifyin
HBOT at 1.5 ATA for 60 min induces hormetic response via Nrf 0.640 neurodegeneration What are the optimal oxygen pressure, du
Age-Stratified Dosing Protocol Reflecting Endogenous Decline 0.640 - What is the optimal dosage and timing of
Mitochondrial NAD+ Salvage Enhancement 0.639 neurodegeneration Gene expression changes in aging mouse b
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in 0.637 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinf 0.628 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Epigenetic clocks association with brain aging patterns in older women exploratory cognitive impairment and demen 0.900 0.00 human patients proposed N/A
Conditional TYROBP Knockdown in Early-Stage 5xFAD Mice Using CRISPRi-A in_vivo Alzheimer's disease 0.746 0.55 5xFAD x Cx3cr1-Cre mice inject proposed $95,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] Yu CH, Davidson S, Harapas CR, Hilton JB Cell 2020 2
Genome-wide methylation profiles reveal quantitative views of human aging rates. [PMID:23177740] Hannum G, Guinney J, Zhao L, Zhang L, Hu Mol Cell 2013 1
Genome-wide consensus transcriptional signatures identify synaptic pruning linki [PMID:41139712] Li H, Xie Z, Tian Y, Zhou R, Yang Y et a Mol Psychiatry 2026 0
The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively reg [PMID:41435829] Rosner D, Sun J, Cacace R, Yee A, Wagh C Neuron 2026 0
Extracellular vesicles from IPFP-MSCs trigger osteoarthritis by transferring mtD [PMID:41480405] Li S, Yan Z, Zhi X, Zheng W, Zhang Z et Bioact Mater 2026 0
Integrative Transcriptomic and Bioinformatics Approaches Combined With Transform [PMID:41524613] Yan D, Li W, Xing E, Wang P, Zhang Z FASEB J 2026 0
Comprehensive multi-omics analysis and experimental validation indicate that VPS [PMID:41531939] Wan D, Qi Y, Kang Y, Liang F, Wang Q et RSC Med Chem 2026 0
Integrated Bioinformatics Analysis of Screen Mitochondrial Autophagy-Related Cor [PMID:41731906] Gao Z, Wang Y, Ren Y, Lyu J J Neurochem 2026 0
VPS35 Deficiency Markedly Reduces the Proliferation of HEK293 Cells. [PMID:41751560] Lee S, Park S, Bang H, Kim SU, Park YH e Genes (Basel) 2026 0
N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in P [PMID:41766663] Song P, Chen C, Franchini R, Duong B, Wa J Clin Invest 2026 0
The VPS35 protein and the role of its impairments in mitochondrial dysfunction i [PMID:41841708] Buneeva OA, Medvedev AE Biomed Khim 2026 0
Vps35 p. D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation [PMID:41846978] Deng IB, Bu M, Follett J, Sharp R, Mamai bioRxiv 2026 0
Lack of Cerebrospinal Fluid α-Synuclein Seeding in VPS35 D620N- and LRRK2 Y1699C [PMID:41912440] Santinelli L, Pratuseviciute N, Lange LM Mov Disord 2026 0
Integrative bioinformatics and machine learning identify shared molecular mechan [PMID:41961800] Deng A, Wang W PLoS One 2026 0
Genome-wide consensus transcriptional signatures identify synaptic pruning linki [PMID:41139712] Li H, Xie Z, Tian Y, Zhou R, Yang Y, Lin Molecular psychiatry 2026 0
The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively reg [PMID:41435829] Rosner D, Sun J, Cacace R, Yee A, Wagh C Neuron 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
DNA methylation and prediction of biological age. [PMID:41602542] Chen Y, Cheng X, Ji S Front Mol Biosci 2025 0
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974] Dai L, Wang J, Meng L, Zhang X, Xiao T, PLoS biology 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying what are the mechanisms by which gut microbio

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning AGE in their description or question text

TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fueling AL

Score: 0.776 · ALS · 2026-04-26

age-linked CpG drift is the actionable driver in: Are DNA methylation changes in

Score: 0.750 · neurodegeneration · 2026-04-26

The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, p

age-linked CpG drift is the actionable driver in: Are age-related DNA methylatio

Score: 0.750 · neurodegeneration · 2026-04-26

The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, p

Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Overexpression

Score: 0.745 · neurodegeneration · 2026-04-12

**Molecular Mechanism and Rationale** The NAD+ salvage pathway represents a critical metabolic hub in neuronal energy h

VPS35 retromer activation prevents endosomal tau templating across all brain reg

Score: 0.740 · neurodegeneration · 2026-04-21

## Mechanistic Overview VPS35 retromer activation prevents endosomal tau templating across all brain regions and disease

Mutant-dependent amplification is context-dependent and strongest in microglia a

Score: 0.740 · neurodegeneration · 2026-04-24

A credible refinement is that any true amplification is not universal across cell types, but emerges most strongly in pr

ATAC-seq accessibility separates causal from compensatory states in: Are age-rel

Score: 0.738 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada

Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Anta

Score: 0.735 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph

Context-Dependent Cx43 Modulation Based on Disease Stage

Score: 0.724 · cell biology · 2026-04-13

## Mechanistic Overview Context-Dependent Cx43 Modulation Based on Disease Stage starts from the claim that modulating G

protective chromatin remodeling defines the therapeutic window for: Are age-rela

Score: 0.723 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell meth

Peripheral Monocyte/Macrophage Infiltration Mimicking Microglial Loss

Score: 0.693 · neuroinflammation · 2026-04-21

**Molecular Mechanism and Rationale** The proposed mechanism centers on liver disease-induced breakdown of blood-brain

PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Subsequent p53 Activat

Score: 0.661 · neurodegeneration · 2026-04-15

## Mechanistic Overview PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Subsequent p53 Activation starts from

Focused Ultrasound with Microbubble Contrast Agents

Score: 0.660 · drug delivery · 2026-04-22

## **Molecular Mechanism and Rationale** The molecular foundation of focused ultrasound (FUS) with microbubble contrast

Plasma D-Dimer Elevation Reflects Fibrinogen Leakage and Secondary Fibrinolysis

Score: 0.660 · unknown disease · 2026-04-26

Plasma fibrinogen leaks across the compromised BBB and undergoes coagulation cascade activation and cross-linking by fac

Radiation drives pericyte senescence through lysosome acidification failure and

Score: 0.652 · neurodegeneration · 2026-04-25

Autophagosomes still form after irradiation, but damaged lysosomes cannot clear cargo, sustaining ROS and SASP output.